Skip to content

Purge Vs no Purge in Living Donor Liver Transplantation Recipients

Graft Portal Reperfusion Without Purging Graft Preservative Solution In Living Donor Liver Transplantation. A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02540447
Acronym
PNP
Enrollment
80
Registered
2015-09-04
Start date
2013-01-31
Completion date
2015-05-31
Last updated
2017-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemia Reperfusion Injury

Keywords

Liver transplantation, Graft rinse, Ischemia reperfusion injury

Brief summary

The investigators tested the impact of purging the graft contents and mesenteric blood into the systemic circulation versus washing out this volume out of the circulation in living donor liver transplantation recipients.

Detailed description

All donors had right hepatectomy. On the back table, surgeons flushed liver grafts with 4 Liters of cold Custodiol solution. Patients were randomized into either purge group (Pg) (n=40) were graft fluid contents were washed out by the patient's portal vein blood (0.5ml per gram graft weight) through incompletely anastomosed hepatic vein, or No purge group (NPg) (n=40) where graft fluid contents were washed into the systemic circulation by the patient's portal blood. The primary outcome objective was the mean arterial blood pressure 5 minutes after portal declamping. Secondary objectives included hemodynamic and oxygenation.

Interventions

PROCEDUREPurge

In the recipient before portal declamping, the graft preservative solution and the mesenteric blood is washed out of the circulation into the abdominal cavity and sucked by external sucker through the incompletely anastomosed hepatic vein prior to portal declamping

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adult living donor liver transplantation recipients of either sex in mansoura liver transplantation program

Exclusion criteria

* re-transplantation * Previous upper abdominal operation * Budd Chiari syndrome

Design outcomes

Primary

MeasureTime frameDescription
Lowest 5 Minutes Post-reperfusion Mean Arterial Blood Pressure5 minutes post-reperfusionThe lowest of three recorded mean arterial pressure readings at 1,3 and 5 minutes after portal declamping

Secondary

MeasureTime frameDescription
Biliary Complications (Participants)3 monthsParticipants who developed biliary complications in three months period (Participant)
Ischemia Reperfusion Injury7 daysincidence of ischemia reperfusion injury in the transplanted graft
Post-operative Infectious Complications30 days
3 Months Mortality3 Monthsmortality within first 3 post-operative months

Countries

Egypt

Participant flow

Recruitment details

Candidates recruited from patients admitted for living donor liver transplantation in Mansoura liver transplantation unit

Participants by arm

ArmCount
Purge
The donor surgical team excised the right liver lobe (without inclusion of the middle hepatic vein) and preserved it on the back table with cold custodiol (4°C solution, Portal vein (PV) was completely anastomosed and the right hepatic vein (RHV) was anastomosed with the recipient hepatic vein apart from last suture that was left for drainage of the liver graft contents of the preservative solution into the peritoneal cavity using portal blood after portal declamping based on the graft volume and suctioned through an external sucker, then completed the RHV anastomosis. Purge of graft contents out of the circulation: In the recipient before portal declamping, the graft preservative solution and the mesenteric blood is washed out of the circulation into the abdominal cavity and sucked by external sucker through the incompletely anastomosed hepatic vein prior to portal declamping
40
No Purge
The donor surgical team excised the right liver lobe (without inclusion of the middle hepatic vein) and preserved it on the back table with cold Custodiol (4°C solution, Both portal vein and RHV were completely anastomosed prior to portal declamping and the graft preservative contents were washed into the systemic circulation by the portal blood at portal declamping.
40
Total80

Baseline characteristics

CharacteristicPurgeNo PurgeTotal
Age, Continuous51.5 years
STANDARD_DEVIATION 6.19
50.9 years
STANDARD_DEVIATION 7.62
51.15 years
STANDARD_DEVIATION 6.94
Region of Enrollment
Egypt
40 participants40 participants80 participants
Sex: Female, Male
Female
8 Participants6 Participants14 Participants
Sex: Female, Male
Male
32 Participants34 Participants66 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
18 / 4015 / 40
serious
Total, serious adverse events
4 / 403 / 40

Outcome results

Primary

Lowest 5 Minutes Post-reperfusion Mean Arterial Blood Pressure

The lowest of three recorded mean arterial pressure readings at 1,3 and 5 minutes after portal declamping

Time frame: 5 minutes post-reperfusion

ArmMeasureValue (MEAN)Dispersion
PurgeLowest 5 Minutes Post-reperfusion Mean Arterial Blood Pressure66.03 mmHgStandard Deviation 6.13
No PurgeLowest 5 Minutes Post-reperfusion Mean Arterial Blood Pressure57.75 mmHgStandard Deviation 5.91
Secondary

3 Months Mortality

mortality within first 3 post-operative months

Time frame: 3 Months

ArmMeasureValue (NUMBER)
Purge3 Months Mortality4 participants
No Purge3 Months Mortality3 participants
Secondary

Biliary Complications (Participants)

Participants who developed biliary complications in three months period (Participant)

Time frame: 3 months

ArmMeasureValue (NUMBER)
PurgeBiliary Complications (Participants)10 participants
No PurgeBiliary Complications (Participants)6 participants
Secondary

Ischemia Reperfusion Injury

incidence of ischemia reperfusion injury in the transplanted graft

Time frame: 7 days

ArmMeasureValue (NUMBER)
PurgeIschemia Reperfusion Injury3 participants
No PurgeIschemia Reperfusion Injury2 participants
Secondary

Post-operative Infectious Complications

Time frame: 30 days

ArmMeasureValue (NUMBER)
PurgePost-operative Infectious Complications9 participants
No PurgePost-operative Infectious Complications8 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026